Bengaluru-based Indegene, a digitally-focused life science marketing company, has announced the acquisition of US-based CultHealth, a full-service healthcare marketing agency for numerous life science brands. life.
Acquisition by ILSL Inc., a subsidiary of Indegene Private Limited, increases Indegene’s commercialization portfolio spanning drug discovery and development through to marketing and sales, adding branding and development capabilities marketplace as well as patient engagement platforms.
Global drug spending is expected to reach $2.1 trillion by 2025. Life science companies in the top 10 countries are expected to launch 290-315 products between 2022 and 2026, representing $196 billion in projected sales. However, only 1 in 5 products launched in the United States reached $1 billion in revenue between 2004 and 2016 and 50% of all products launched in the past 15 years did not peak. US sales of $250 million.
In an increasingly complex business and regulatory environment, life sciences companies seek deep branding and marketing expertise as they explore modern, data-driven ways to drive success launch and create a personalized brand experience with omnichannel engagement journeys for patients and physicians.